Effects of Terlipressin on Renal Perfusion in Patients With Septic Shock

NACompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

September 1, 2019

Primary Completion Date

May 31, 2020

Study Completion Date

June 28, 2020

Conditions
Septic Shock
Interventions
DRUG

Terlipressin treatment

Patients in the terlipressin group received a fixed dose of terlipressin added to usual care. Terlipressin was intravenously pumped at a fixed dose of 1.3μg/kg/hour for 24 hours.

DRUG

Usual care

Patients in the usual care group were treated with standard care, according to the international guidelines for the management of sepsis and septic shock.

Trial Locations (1)

210000

Nanjing Zhongda Hospital, Southeast University, Nanjing

All Listed Sponsors
lead

Southeast University, China

OTHER

NCT04948372 - Effects of Terlipressin on Renal Perfusion in Patients With Septic Shock | Biotech Hunter | Biotech Hunter